Biotechnology Business

Study Affirms BIOTRONIK Home Monitoring® Leads to Earlier Intervention

Published in Law and Health Weekly, June 27th, 2009

BIOTRONIK Inc. announced the landmark TRUST (Lumax-T/Lumos-T safely reduces routine office device follow-up) study affirms that automatic early detection of clinical events by BIOTRONIK Home Monitoring® leads to earlier intervention than conventional in-office follow-ups.

As a result, the company is updating its labeling instructions to show how physicians can reduce the number of patient visits to their office for routine device follow-up without compromising the quality of care these patients receive.

BIOTRONIK pioneered wireless remote technology more than eight years ago in the United States and is still the leader in this technology today....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2009-06-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry